{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:33:01Z","timestamp":1792859581515,"version":"4.5.0"},"reference-count":154,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2021,1,5]]},"abstract":"<jats:p>Background: Clinicopathological studies have demonstrated that Alzheimer\u2019s disease dementia (ADD) is often accompanied by clinically undetectable comorbid neurodegenerative and cerebrovascular disease that alter the rate of cognitive decline. Aside from causing increased variability in clinical response, it is possible that the major ADD comorbidities may not respond to ADD-specific molecular therapeutics. Objective: As most reports have focused on comorbidity in the oldest-old, its extent in younger age groups that are more likely to be involved in clinical trials is largely unknown; our objective is to provide this information. Methods: We conducted a survey of neuropathological comorbidities in sporadic ADD using data from the US National Alzheimer\u2019s Coordinating Center. Subject data was restricted to those with dementia and meeting National Institute on Aging-Alzheimer\u2019s Association intermediate or high AD Neuropathological Change levels, excluding those with known autosomal dominant AD-related mutations. Results: Highly prevalent ADD comorbidities are not restricted to the oldest-old but are common even in early-onset ADD. The percentage of cases with ADD as the sole major neuropathological diagnosis is highest in the under-60 group, where \u201cpure\u201d ADD cases are still in the minority at 44%. After this AD as a sole major pathology in ADD declines to roughly 20%in the 70s and beyond. Lewy body disease is the most common comorbidity at younger ages but actually is less common at later ages, while for most others, their prevalence increases with age. Conclusion: Alzheimer\u2019s disease neuropathological comorbidities are highly prevalent even in the younger-old.<\/jats:p>","DOI":"10.3233\/jad-201213","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T16:02:34Z","timestamp":1606838554000},"page":"389-400","source":"Crossref","is-referenced-by-count":80,"title":["Alzheimer\u2019s Disease Neuropathological Comorbidities are Common in the Younger-Old"],"prefix":"10.1177","volume":"79","author":[{"given":"Thomas G.","family":"Beach","sequence":"first","affiliation":[{"name":"Banner Sun Health Research Institute, Sun City, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Malek-Ahmadi","sequence":"additional","affiliation":[{"name":"Banner Alzheimer\u2019s Institute, Phoenix, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-201213_ref1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00401-001-0493-5","article-title":"Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly","volume":"103","author":"Zekry","year":"2002","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.3233\/JAD-201213_ref2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00702-014-1288-x","article-title":"Challenges of multimorbidity of the aging brain: A critical update","volume":"122","author":"Jellinger","year":"2015","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-201213_ref3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ana.25246","article-title":"Combined neuropathological pathways account for age-related risk of dementia","volume":"84","author":"Power","year":"2018","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201213_ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2015.10.009","article-title":"Brain pathologies in extreme old age","volume":"37","author":"Neltner","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-201213_ref5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000161560","article-title":"Mixed brain pathologies in dementia: The BrainNet Europe consortium experience","volume":"26","author":"Kovacs","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-201213_ref6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13195-014-0082-1","article-title":"Prevalence of mixed pathologies in the aging brain","volume":"6","author":"Rahimi","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-201213_ref7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2174\/15672050113109990002","article-title":"Neuropathological correlates of cerebral multimorbidity","volume":"10","author":"Attems","year":"2013","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-201213_ref8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jns.2007.01.045","article-title":"Neuropathological evaluation of mixed dementia","volume":"257","author":"Jellinger","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-201213_ref9","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jalz.2016.04.006","article-title":"Microinfarcts are common and strongly related to dementia in the oldest-old: The 90+study","volume":"12","author":"Corrada","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201213_ref10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.STR.0000110791.51378.4E","article-title":"Cortical microinfarcts and demyelination significantly affect cognition in brain aging","volume":"35","author":"Kovari","year":"2004","journal-title":"Stroke"},{"key":"10.3233\/JAD-201213_ref11","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1093\/brain\/aww224","article-title":"TDP-43 stage, mixed pathologies, and clinical Alzheimer\u2019s-type dementia","volume":"139","author":"James","year":"2016","journal-title":"Brain"},{"key":"10.3233\/JAD-201213_ref12","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1001\/jama.2012.3556","article-title":"Dementia from Alzheimer disease and mixed pathologies in the oldest old","volume":"307","author":"James","year":"2012","journal-title":"JAMA"},{"key":"10.3233\/JAD-201213_ref13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ana.25380","article-title":"Attributable risk of Alzheimer\u2019s dementia attributed to age-related neuropathologies","volume":"85","author":"Boyle","year":"2019","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201213_ref14","first-page":"804","article-title":"Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline","volume":"140","author":"Boyle","year":"2017","journal-title":"Brain"},{"key":"10.3233\/JAD-201213_ref15","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref16","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.23964","article-title":"Much of late life cognitive decline is not due to common neurodegenerative pathologies","volume":"74","author":"Boyle","year":"2013","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201213_ref17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s40478-019-0752-0","article-title":"Alzheimer\u2019s disease frequency peaks in the tenth decade and is lower afterwards","volume":"7","author":"Farfel","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-201213_ref18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","article-title":"Impact of multiple pathologies on the threshold for clinically overt dementia","volume":"134","author":"Kapasi","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201213_ref19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neurobiolaging.2017.08.029","article-title":"Age and the association of dementia-related pathology with trajectories of cognitive decline","volume":"61","author":"Jansen","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-201213_ref20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00401-018-1872-5","article-title":"Non-Alzheimer\u2019s contributions to dementia and cognitive resilience in The 90+Study","volume":"136","author":"Robinson","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201213_ref21","doi-asserted-by":"crossref","first-page":"e0217566","DOI":"10.1371\/journal.pone.0217566","article-title":"Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease","volume":"14","author":"Malek-Ahmadi","year":"2019","journal-title":"PLoS One"},{"key":"10.3233\/JAD-201213_ref22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archneurol.2011.157","article-title":"Ecology of the aging human brain","volume":"68","author":"Sonnen","year":"2011","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-201213_ref23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neurobiolaging.2017.01.017","article-title":"Alzheimer\u2019s disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples","volume":"53","author":"Brenowitz","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-201213_ref24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1037\/neu0000282","article-title":"Temporal course of neurodegenerative effects on cognition in old age","volume":"30","author":"Wilson","year":"2016","journal-title":"Neuropsychology"},{"key":"10.3233\/JAD-201213_ref25","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.mayocp.2017.02.011","article-title":"Alzheimer Disease: Scientific Breakthroughs and Translational Challenges","volume":"92","author":"Caselli","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.3233\/JAD-201213_ref26","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1212\/WNL.0000000000002480","article-title":"Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies","volume":"86","author":"White","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref27","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/WNL.0000000000001831","article-title":"Multiple pathologies are common and related to dementia in the oldest-old: The 90+Study","volume":"85","author":"Kawas","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ana.21208","article-title":"Pathological correlates of dementia in a longitudinal, population-based sample of aging","volume":"62","author":"Sonnen","year":"2007","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201213_ref29","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2174\/156720511795745302","article-title":"Cognition and neuropathology in aging: Multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project","volume":"8","author":"Negash","year":"2011","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-201213_ref31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/NEN.0000000000000028","article-title":"Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates","volume":"73","author":"Dugger","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-201213_ref32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-140162","article-title":"Positive florbetapir PET amyloid imaging in a subject with frequent cortical neuritic plaques and frontotemporal lobar degeneration with TDP43-positive inclusions","volume":"42","author":"Serrano","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201213_ref33","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/STROKEAHA.110.595082","article-title":"Microinfarct pathology, dementia, and cognitive systems","volume":"42","author":"Arvanitakis","year":"2011","journal-title":"Stroke"},{"key":"10.3233\/JAD-201213_ref34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40478-018-0531-3","article-title":"TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer\u2019s disease","volume":"6","author":"Nag","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-201213_ref35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1750-3639.2008.00244.x","article-title":"Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons","volume":"20","author":"Nelson","year":"2010","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-201213_ref36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/bpa.12505","article-title":"Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi","volume":"28","author":"Smith","year":"2018","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-201213_ref37","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1474-4422(17)30284-3","article-title":"Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer\u2019s disease: A longitudinal retrospective study","volume":"16","author":"Josephs","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-201213_ref38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00401-014-1269-z","article-title":"TDP-43 is a key player in the clinical features associated with Alzheimer\u2019s disease","volume":"127","author":"Josephs","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201213_ref39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1212\/WNL.51.2.351","article-title":"Cognitive decline is faster in Lewy body variant than in Alzheimer\u2019s disease","volume":"51","author":"Olichney","year":"1998","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref40","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-161109","article-title":"Long-term cognitive decline in dementia with Lewy bodies in a large multicenter, international cohort","volume":"57","author":"Kramberger","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201213_ref41","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jalz.2016.09.015","article-title":"Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample","volume":"13","author":"Brenowitz","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201213_ref42","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/01.WNL.0000165987.89198.65","article-title":"Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both","volume":"64","author":"Kraybill","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref43","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3233\/JAD-2009-1105","article-title":"Neuropathology-based risk scoring for dementia diagnosis in the elderly","volume":"17","author":"Haneuse","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201213_ref44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ana.25123","article-title":"Person-specific contribution of neuropathologies to cognitive loss in old age","volume":"83","author":"Boyle","year":"2018","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201213_ref45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/jnen\/nlz126","article-title":"Limbic predominant age-related TDP-43 encephalopathy (LATE): Clinical and neuropathological associations","volume":"79","author":"Besser","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-201213_ref46","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1212\/01.WNL.0000136241.71716.72","article-title":"Hippocampal sclerosis dementia: Expanding the phenotypes of frontotemporal dementias?","volume":"63","author":"Lippa","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11910-015-0592-7","article-title":"Update on hippocampal sclerosis","volume":"15","author":"Dutra","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.3233\/JAD-201213_ref48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00401-013-1154-1","article-title":"Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease","volume":"126","author":"Nelson","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201213_ref49","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00401-011-0826-y","article-title":"Alzheimer\u2019s disease is not \u201cbrain aging\u201d: Neuropathological, genetic, and epidemiological human studies","volume":"121","author":"Nelson","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201213_ref50","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-020-02211-0","article-title":"Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy","volume":"140","author":"Katsumata","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201213_ref51","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3233\/JAD-180169","article-title":"TDP-43 and alzheimer\u2019s disease pathologic subtype in non-amnestic Alzheimer\u2019s disease dementia","volume":"64","author":"Sahoo","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201213_ref52","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3233\/JAD-132351","article-title":"TDP-43 pathology in the population: Prevalence and associations with dementia and age","volume":"42","author":"Keage","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201213_ref53","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ana.24493","article-title":"TAR DNA-binding protein 43 and pathological subtype of Alzheimer\u2019s disease impact clinical features","volume":"78","author":"Josephs","year":"2015","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201213_ref54","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1212\/WNL.0000000000003610","article-title":"TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD","volume":"88","author":"Nag","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref55","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/WAD.0000000000000334","article-title":"Association of TDP-43 pathology with domain-specific literacy in older persons","volume":"33","author":"Kapasi","year":"2019","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-201213_ref56","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1093\/brain\/awm228","article-title":"Identification of Alzheimer and vascular lesion thresholds for mixed dementia","volume":"130","author":"Gold","year":"2007","journal-title":"Brain"},{"key":"10.3233\/JAD-201213_ref57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13195-018-0450-3","article-title":"Prediction models for dementia and neuropathology in the oldest old: The Vantaa 85+cohort study","volume":"11","author":"Hall","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-201213_ref58","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/acn3.389","article-title":"Population-based analysis of pathological correlates of dementia in the oldest old","volume":"4","author":"Tanskanen","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-201213_ref59","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neurobiolaging.2018.05.027","article-title":"Watershed microinfarct pathology and cognition in older persons","volume":"70","author":"Kapasi","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-201213_ref60","first-page":"85","article-title":"The effect of vascular neuropathology on late-life cognition: Results from the SMART Project","volume":"3","author":"Kryscio","year":"2016","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-201213_ref61","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/jnnp.51.8.1037","article-title":"Accuracy of the clinical diagnosis of vascular dementia: A prospective clinical and post-mortem neuropathological study","volume":"51","author":"Erkinjuntti","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-201213_ref62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(90)90052-O","article-title":"Vascular dementia. A clinicopathological study","volume":"96","author":"del","year":"1990","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-201213_ref63","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1212\/01.WNL.0000055863.87435.B2","article-title":"Relation of cerebral infarctions to dementia and cognitive function in older persons","volume":"60","author":"Schneider","year":"2003","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref64","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1212\/01.WNL.0000118211.78503.F5","article-title":"Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology","volume":"62","author":"Schneider","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-510X(02)00282-4","article-title":"The pathology of ischemic-vascular dementia: An update","volume":"203-204","author":"Jellinger","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-201213_ref66","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1749-6632.2000.tb06373.x","article-title":"Which vascular lesions are of importance in vascular dementia?","volume":"903","author":"Esiri","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-201213_ref67","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S1474-4422(17)30196-5","article-title":"Detection, risk factors, and functional consequences of cerebral microinfarcts","volume":"16","author":"van Veluw","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-201213_ref68","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1179\/016164104225017668","article-title":"Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer\u2019s disease","volume":"26","author":"Kalback","year":"2004","journal-title":"Neurol Res"},{"key":"10.3233\/JAD-201213_ref69","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/neup.12189","article-title":"Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program","volume":"35","author":"Beach","year":"2015","journal-title":"Neuropathology"},{"key":"10.3233\/JAD-201213_ref70","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/WAD.0000000000000279","article-title":"Version 3 of the National Alzheimer\u2019s Coordinating Center\u2019s Uniform Data Set","volume":"32","author":"Besser","year":"2018","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-201213_ref71","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jnen\/nly049","article-title":"The Revised National Alzheimer\u2019s Coordinating Center\u2019s neuropathology form-available data and new analyses","volume":"77","author":"Besser","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-201213_ref72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201213_ref73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201213_ref74","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref75","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","article-title":"Staging of neurofibrillary pathology in Alzheimer\u2019s disease: A study of the BrainNet Europe Consortium","volume":"18","author":"Alafuzoff","year":"2008","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-201213_ref76","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201213_ref77","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref78","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"10.3233\/JAD-201213_ref79","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nrneurol.2013.105","article-title":"Dementia in the oldest old","volume":"9","author":"Yang","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-201213_ref80","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/jnen\/nlw033","article-title":"\u201cNew Old Pathologies\u201d: AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS)","volume":"75","author":"Nelson","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-201213_ref81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(97)00294-2","article-title":"Further evidence for an association between a mutation in the APP gene and Lewy body formation","volume":"227","author":"Halliday","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-201213_ref82","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jnen\/nlv028","article-title":"Neuropathology of autosomal dominant Alzheimer disease in the National Alzheimer Coordinating Center Database","volume":"75","author":"Ringman","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-201213_ref83","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ana.20393","article-title":"A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer\u2019s disease","volume":"57","author":"Ishikawa","year":"2005","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201213_ref84","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s004019900155","article-title":"Lewy body and Alzheimer pathology in a family with the amyloid-beta precursor protein APP717 gene mutation","volume":"100","author":"Rosenberg","year":"2000","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201213_ref85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3940(94)90666-1","article-title":"Lewy bodies in the brain of two members of a family with the 717 (Val to Ile) mutation of the amyloid precursor protein gene","volume":"172","author":"Lantos","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-201213_ref86","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0002-9440(10)65722-7","article-title":"Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer\u2019s disease patients with mutations in presenilin and amyloid precursor protein genes","volume":"153","author":"Lippa","year":"1998","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-201213_ref87","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archneur.63.3.370","article-title":"Lewy body pathology in familial Alzheimer disease: Evidence for disease- and mutation-specific pathologic phenotype","volume":"63","author":"Leverenz","year":"2006","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-201213_ref88","doi-asserted-by":"crossref","first-page":"13092","DOI":"10.1523\/JNEUROSCI.4244-07.2007","article-title":"Enhanced accumulation of phosphorylated alpha-synuclein and elevated beta-amyloid 42\/40 ratio caused by expression of the presenilin-1 deltaT440 mutant associated with familial Lewy body disease and variant Alzheimer\u2019s disease","volume":"27","author":"Kaneko","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201213_ref89","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0197-4580(91)90007-7","article-title":"Gelsolin variant and beta-amyloid co-occur in a case of Alzheimer\u2019s with Lewy bodies","volume":"12","author":"Haltia","year":"1991","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-201213_ref90","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/1097-0029(20000701)50:1<10::AID-JEMT3>3.0.CO;2-6","article-title":"Neuropathology of Gerstmann-Straussler-Scheinker disease","volume":"50","author":"Bugiani","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.3233\/JAD-201213_ref91","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3233\/JAD-2006-9302","article-title":"Lewy body pathology in late-onset familial Alzheimer\u2019s disease: A clinicopathological case series","volume":"9","author":"Tsuang","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201213_ref92","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","article-title":"Alzheimer disease with amygdala Lewy bodies: A distinct form of alpha-synucleinopathy","volume":"65","author":"Uchikado","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-201213_ref93","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer\u2019s disease: A neuropathological review of 145 cases using alpha-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-201213_ref94","first-page":"141","article-title":"Limbic neuropathology in idiopathic Parkinson\u2019s disease with concomitant dementia","volume":"42","author":"Bertrand","year":"2004","journal-title":"Folia Neuropathol"},{"key":"10.3233\/JAD-201213_ref95","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00401-003-0705-2","article-title":"Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson\u2019s disease","volume":"106","author":"Kovari","year":"2003","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.3233\/JAD-201213_ref96","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s004019900168","article-title":"Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson\u2019s disease","volume":"100","author":"Mattila","year":"2000","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.3233\/JAD-201213_ref97","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","article-title":"Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease","volume":"54","author":"Hurtig","year":"2000","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref98","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","article-title":"Cognitive status correlates with neuropathologic stage in Parkinson disease","volume":"64","author":"Braak","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref99","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000197890","article-title":"Significance of brain lesions in Parkinson disease dementia and Lewy body dementia","volume":"24","author":"Jellinger","year":"2009","journal-title":"Front Neurol Neurosci"},{"key":"10.3233\/JAD-201213_ref100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.0b013e3181c7da8e","article-title":"In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia","volume":"74","author":"Burack","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref101","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.23659","article-title":"Neuropathologic substrates of Parkinson disease dementia","volume":"72","author":"Irwin","year":"2012","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201213_ref102","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/WAD.0b013e31819c5ef4","article-title":"Parkinson disease with dementia: Comparing patients with and without Alzheimer pathology","volume":"23","author":"Sabbagh","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-201213_ref103","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: Which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain"},{"key":"10.3233\/JAD-201213_ref104","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson\u2019s disease: The inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-201213_ref105","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mdc3.12290","article-title":"Amyloid-beta positron emission tomography imaging of Alzheimer\u2019s pathology in Parkinson\u2019s disease dementia","volume":"3","author":"Akhtar","year":"2016","journal-title":"Mov Disord Clin Pract"},{"key":"10.3233\/JAD-201213_ref106","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.jnen.0000205145.54457.ea","article-title":"Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies","volume":"65","author":"Deramecourt","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-201213_ref107","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jamaneurol.2016.4926","article-title":"Duration and pathologic correlates of Lewy body disease","volume":"74","author":"Graff-Radford","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-201213_ref108","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00002093-200210000-00001","article-title":"Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank","volume":"16","author":"Barker","year":"2002","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-201213_ref109","doi-asserted-by":"crossref","first-page":"e0231720","DOI":"10.1371\/journal.pone.0231720","article-title":"Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer\u2019s disease dementia","volume":"15","author":"Beach","year":"2020","journal-title":"PLoS One"},{"key":"10.3233\/JAD-201213_ref110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/0891988716656083","article-title":"Revisiting DLB diagnosis: A consideration of prodromal DLB and of the diagnostic overlap with Alzheimer disease","volume":"29","author":"McKeith","year":"2016","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.3233\/JAD-201213_ref111","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neurol.2013.05.004","article-title":"[Dementia: Where are the Lewy bodies?]","volume":"169","author":"Lebouvier","year":"2013","journal-title":"Rev Neurol (Paris)"},{"key":"10.3233\/JAD-201213_ref112","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00415-009-5324-y","article-title":"Low sensitivity in clinical diagnoses of dementia with Lewy bodies","volume":"257","author":"Nelson","year":"2010","journal-title":"J Neurol"},{"key":"10.3233\/JAD-201213_ref113","doi-asserted-by":"crossref","first-page":"e0217566","DOI":"10.1371\/journal.pone.0217566","article-title":"Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease","volume":"14","author":"Malek-Ahmadi","year":"2019","journal-title":"PLoS One"},{"key":"10.3233\/JAD-201213_ref114","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jalz.2017.09.014","article-title":"The limbic and neocortical contribution of alpha-synuclein, tau, and amyloid beta to disease duration in dementia with Lewy bodies","volume":"14","author":"Ferman","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201213_ref115","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","article-title":"Unified staging system for Lewy body disorders: Correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201213_ref116","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref117","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref118","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/ane.13028","article-title":"Lewy body pathology in Alzheimer\u2019s disease: A clinicopathological prospective study","volume":"139","author":"Savica","year":"2019","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-201213_ref119","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.410190306","article-title":"A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study","volume":"19","author":"Brun","year":"1986","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201213_ref120","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/brain\/111.6.1425","article-title":"White matter changes in dementia of Alzheimer\u2019s type. Biochemical and neuropathological correlates","volume":"111","author":"Englund","year":"1988","journal-title":"Brain"},{"key":"10.3233\/JAD-201213_ref121","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/archneur.1991.00530220031015","article-title":"Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain","volume":"48","author":"Mirsen","year":"1991","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-201213_ref122","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","article-title":"White matter hyperintensities, cognitive impairment and dementia: An update","volume":"11","author":"Prins","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-201213_ref123","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/jnnp.54.1.46","article-title":"Could Wallerian degeneration contribute to \u201cleuko-araiosis\u201d in subjects free of any vascular disorder?","volume":"54","author":"Leys","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-201213_ref124","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00401-009-0635-8","article-title":"Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer\u2019s disease, and dementia with Lewy bodies","volume":"119","author":"Ihara","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201213_ref125","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1212\/WNL.0b013e318200d6f9","article-title":"Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old","volume":"75","author":"Polvikoski","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref126","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/j.1530-0277.2012.01808.x","article-title":"Callosal white matter microstructural recovery in abstinent alcoholics: A longitudinal diffusion tensor imaging study","volume":"36","author":"Alhassoon","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"key":"10.3233\/JAD-201213_ref127","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1533317513517045","article-title":"Interactive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adults","volume":"29","author":"Foley","year":"2014","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3233\/JAD-201213_ref128","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1533317515578257","article-title":"Mild cognitive impairment is associated with white matter integrity changes in late-myelinating regions within the corpus callosum","volume":"31","author":"Stricker","year":"2016","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3233\/JAD-201213_ref129","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1017\/S1355617713000660","article-title":"Decreased white matter integrity in neuropsychologically defined mild cognitive impairment is independent of cortical thinning","volume":"19","author":"Stricker","year":"2013","journal-title":"J Int Neuropsychol Soc"},{"key":"10.3233\/JAD-201213_ref130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuroimage.2008.11.027","article-title":"Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer\u2019s disease supports retrogenesis","volume":"45","author":"Stricker","year":"2009","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-201213_ref131","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/jnnp.69.4.528","article-title":"Loss of connectivity in Alzheimer\u2019s disease: An evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging","volume":"69","author":"Rose","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-201213_ref132","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/13825585.2019.1628916","article-title":"Domain-specific cognitive effects of white matter pathology in old age, mild cognitive impairment and Alzheimer\u2019s disease","volume":"27","author":"Kaskikallio","year":"2020","journal-title":"Neuropsychol Dev Cogn B Aging Neuropsychol Cogn"},{"key":"10.3233\/JAD-201213_ref133","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1212\/01.WNL.0000130530.55104.B5","article-title":"White matter lesions impair frontal lobe function regardless of their location","volume":"63","author":"Tullberg","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JAD-201213_ref134","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/joim.12352","article-title":"White matter changes in familial Alzheimer\u2019s disease","volume":"278","author":"Li","year":"2015","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-201213_ref135","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ana.24647","article-title":"White matter hyperintensities are a core feature of Alzheimer\u2019s disease: Evidence from the dominantly inherited Alzheimer network","volume":"79","author":"Lee","year":"2016","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-201213_ref136","first-page":"187","article-title":"Subjects harboring presenilin familial Alzheimer\u2019s disease mutations exhibit diverse white matter biochemistry alterations","volume":"2","author":"Roher","year":"2013","journal-title":"Am J Neurodegener Dis"},{"key":"10.3233\/JAD-201213_ref137","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fneur.2012.00103","article-title":"Intracerebral hemorrhage in the oldest old: A population-based study (Vantaa 85+)","volume":"3","author":"Tanskanen","year":"2012","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-201213_ref138","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.jalz.2012.10.011","article-title":"Focal hemosiderin deposits and beta-amyloid load in the ADNI cohort","volume":"9","author":"Kantarci","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201213_ref139","doi-asserted-by":"crossref","unstructured":"Wu A , Sharrett AR , Gottesman RF , Power MC , Mosley TH Jr. , Jack CR Jr. , Knopman DS , Windham BG , Gross AL , Coresh J (2019) Association of brain magnetic resonance imaging signs with cognitive outcomes in persons with nonimpaired cognition and mild cognitive impairment. JAMA Netw Open 2, e193359.","DOI":"10.1001\/jamanetworkopen.2019.3359"},{"key":"10.3233\/JAD-201213_ref141","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00401-006-0043-2","article-title":"Argyrophilic grain disease: Frequency and neuropathology in centenarians","volume":"111","author":"Ding","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201213_ref142","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1590\/S1980-57642015DN91000002","article-title":"Argyrophilic grain disease: An underestimated tauopathy","volume":"9","author":"Rodriguez","year":"2015","journal-title":"Dement Neuropsychol"},{"key":"10.3233\/JAD-201213_ref143","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/neup.12429","article-title":"Neuropathological comorbidity associated with argyrophilic grain disease","volume":"38","author":"Yokota","year":"2018","journal-title":"Neuropathology"},{"key":"10.3233\/JAD-201213_ref144","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40478-016-0330-7","article-title":"ARTAG in the basal forebrain: Widening the constellation of astrocytic tau pathology","volume":"4","author":"Liu","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-201213_ref145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/bpa.12536","article-title":"Protein astrogliopathies in human neurodegenerative diseases and aging","volume":"27","author":"Kovacs","year":"2017","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-201213_ref146","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/WAD.0b013e318199d833","article-title":"Correlation of clinical features with argyrophilic grains at autopsy","volume":"23","author":"Sabbagh","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-201213_ref147","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-201213_ref148","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/mds.25327","article-title":"Accuracy of the National Institute for Neurological Disorders and Stroke\/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy","volume":"28","author":"Respondek","year":"2013","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-201213_ref149","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1440-1789.2009.01032.x","article-title":"Clinical heterogeneity in progressive supranuclear palsy: Problems of clinical diagnostic criteria of NINDS-SPSP in a retrospective study of seven Japanese autopsy cases","volume":"30","author":"Sakamoto","year":"2010","journal-title":"Neuropathology"},{"key":"10.3233\/JAD-201213_ref150","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/mds.26054","article-title":"The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases","volume":"29","author":"Respondek","year":"2014","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-201213_ref151","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00401-016-1665-7","article-title":"Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: A forensic autopsy series","volume":"133","author":"Yoshida","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-201213_ref152","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/mds.27485","article-title":"Importance of low diagnostic accuracy for early Parkinson\u2019s disease","volume":"33","author":"Beach","year":"2018","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-201213_ref153","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1272\/jnms.82.266","article-title":"Early stage of progressive supranuclear palsy: A neuropathological study of 324 consecutive autopsy cases","volume":"82","author":"Nogami","year":"2015","journal-title":"J Nippon Med Sch"},{"key":"10.3233\/JAD-201213_ref154","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/mds.27034","article-title":"Which ante mortem clinical features predict progressive supranuclear palsy pathology?","volume":"32","author":"Respondek","year":"2017","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-201213_ref155","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1212\/01.wnl.0000285287.99923.3c","article-title":"Race\/ethnic differences in AD survival in US Alzheimer\u2019s Disease Centers","volume":"70","author":"Mehta","year":"2008","journal-title":"Neurology"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-201213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:34Z","timestamp":1777370674000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-201213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":154,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-201213","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.01.03.894451","asserted-by":"object"}]},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]}}}